As U.S. tariff policy continues to evolve, investors are facing more questions than answers. RBC Economics provides a roadmap on when and where tariffs will start to impact the U.S.

The U.S. government’s fiscal outlook can no longer be ignored.

A dramatic shift in the appetite for equity and fixed income securities issued outside of North America has emerged in 2025. We examine the causes, what they mean for international stocks, and how investors may want to position portfolios.

Professional women’s sports are thriving. A new study reveals this sector's long-term potential for sustainable growth, ROI and making a positive impact.

Running up debts to buy foreign goods is unsustainable in the long term. Identifying the problem is simple, but we see no easy or quick escape for the U.S. from the imbalances built up over the last four decades.

Formulating a plan with the guidance of a financial advisor can help keep investors on track through the ups and downs of the markets.

Everyone has an opinion regarding the COVID-19 crisis; while they may all mean well, no one knows when this will end. They only thing that is true in every crisis I’ve been through (19 in 42 years), human nature does not change. You can measure fear.

The Coronavirus is changing how biotechs will be valued in the future. New technological innovations and a faster FDA approval process will contribute to future growth for these companies.

Market volatility is normal and to be expected. It is painful sometimes, but there are abundant opportunities if you are patient and stick to your strategy.